[1]Lai CL, Chien RN, Leung NW, et al. A one-year trial of lamivudine for chronic hepatitis B[J]. N Engl J Med, 1998,339(2):61-68.
[2]Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, et al. Long-term therapy with adefovirdipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years[J]. Gastroenterology, 2006,131(6):1743-1751.
[3]Lai CL, Gane E, Liaw YF, et al. Telbivudine versus lamivudine in patients with chronichepatitis B[J]. N Engl J Med, 2007, 357(25):2576-2588.
[4]Lai CL, Shouval D, Lok AS, et al. Entecavir versus lamivudine for patients withHBeAg-negative chronic hepatitis B[J]. N Engl J Med, 2006, 354(10):1011-1020.
[5]中华医学会肝病分会中华医学感染病学分会.慢性乙型肝炎防治指南[J]. 中国肝病学杂志, 2011, 19(1):13-33.
[6]苏超,张桂霞,王瑞峰,等. CKD-EPI方程估算中国慢性肾脏病患者肾小球滤过率的适用性评价[J].中华疾病控制杂志, 2013, 17(7):621-624.
[7]Perrillo R, Hann HW, Mutimer D, et al. Adefovirdipivoxil added to ongoing lamivudine inchronic hepatitis B with YMDD mutant hepatitis B virus[J].Gastroenterology, 2004,126(1):81-90.
[8]Shimohata H,Sakai S,Ogawa Y, et al. Osteomalacia due to Fanconi's syndrome and renal failure caused by long-term low-doseadefovir dipivoxil[J].Clin Exp Nephrol, 2013,17(1):147-148.
[9]Tanaka M, Setoguchi T, Ishidou Y, et al. Pathological femoral fractures due to osteomalacia associated withadefovir dipivoxiltreatment for hepatitis B: a case report[J].Diagn Pathol, 2012,7:108.
[10]Li L, Dong GF, Zhang X, et al. Adefovir dipivoxil-induced Fanconi syndrome and hypophosphatemic osteomalacia associated with muscular weakness in a patient withchronic hepatitis B[J].Nan Fang Yi Ke Da Xue Xue Bao,2011,31(11):1956.
[11]Sun XF, Zhang HB, Li XP, et al. A case ofadefovirdipivoxilinduced hypophosphataemicosteomalacia and literature review[J]. Zhonghua Nei Ke Za Zhi, 2011, 50(9):754-757.
[12]Gara N,Zhao X,Collins MT, et al. Renal tubular dysfunction during long-term adefovir or tenofovir therapy inchronic hepatitis B[J].Aliment Pharmacol Ther, 2012, 35(11):1317-1325.
[13]Qi X,Wang JY,Mao RC, et al. Impact of nucleos(t)ide analogues on the estimated glomerular filtration rate in patients withchronic hepatitis B: a prospective cohort study in China[J].J Viral Hepat,2015,22(1):46-54.
[14]Amarapurkar DN,Patel N.Increased eGFR withtelbivudinein combination therapy ofchronic hepatitis Binfection[J].Indian J Gastroenterol,2014,33(1):89-91.
[15]Qi X,Wang J,Chen L, et al. Impact of nucleos(t)ide analogue combination therapy on the estimated glomerular filtration rate in patients with chronic hepatitis B[J].Medicine (Baltimore),2015,94(15):e646.
[16]Wang X,Zhang C,Zhu Y, et al. Efficacy of 2years ofentecavirplus adefovir therapy in patients withchronic hepatitis Bwho had failed on prior nucleos(t)ide analog treatment[J].Antiviral Res, 2014, 103:71-77. |